The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Epidemiological Features of NAFLD From 1999 to 2018 in China
Abstract
With dramatic changes in lifestyles over the last 20 years, nonalcoholic fatty liver disease (NAFLD) has become the most prevalent liver disorder in China but has not received sufficient attention. NAFLD‐related advanced liver disease and its mortality along with its overall disease burden are expected to increase substantially. There is thus an imperative need to clarify the epidemiological features of NAFLD to guide a holistic approach to management. We summarize eight epidemiological features of NAFLD in China over the past two decades using systematic review and meta‐analysis methodology. Our data reveal a rapid growth in the NAFLD population, especially among younger individuals. Importantly, there is a strong ethnic difference in body mass index (BMI) and genetic risk of NAFLD compared with the US population. The etiology of advanced liver disease and its complications (e.g., hepatocellular carcinoma) has been altered because of a Westernized lifestyle and the implementation of effective vaccination strategies against viral hepatitis. Regional epidemiological patterns of NAFLD indicate that economics, environment, and lifestyle are critical factors in disease progression. The analysis also indicates that a large number of patients remain undiagnosed and untreated because of the inadequacy of diagnostic tools and the absence of effective pharmacologic therapies. Given the burden of NAFLD, future policy and research efforts need to address knowledge gaps to mitigate the risk burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Younossi, Z. M., Blissett, D., Blissett, R., Henry, L., Stepanova, M., Younossi, Y., Racila, A., Hunt, S., & Beckerman, R. (2016) · Hepatology · doi:10.1002/hep.28785 · Cited by 1,285
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Diehl, A. M., & Day, C. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1503519 · Cited by 1,283
The global burden of liver disease: The major impact of China
Wang, F., Fan, J., Zhang, Z., Gao, B., & Wang, H. (2014) · Hepatology · doi:10.1002/hep.27406 · Cited by 1,261
New trends on obesity and NAFLD in Asia
Fan, J.-G., Kim, S.-U., & Wong, V. W.-S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.003 · Cited by 1,083
Li, J., Zou, B., Yeo, Y. H., Feng, Y., Xie, X., Lee, D. H., Fujii, H., Wu, Y., Kam, L. Y., Ji, F., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30039-1 · Cited by 1,031
Younossi, Z., Stepanova, M., Ong, J. P., Jacobson, I. M., Bugianesi, E., Duseja, A., Eguchi, Y., Wong, V. W., Negro, F., Yilmaz, Y., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.05.057 · Cited by 806
Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis
Marengo, A., Rosso, C., & Bugianesi, E. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-090514-013832 · Cited by 755
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Lonardo, A., Nascimbeni, F., Mantovani, A., & Targher, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.021 · Cited by 736
Musso, G., Cassader, M., Rosina, F., & Gambino, R. (2012) · Diabetologia · doi:10.1007/s00125-011-2446-4 · Cited by 661
Incidence and Etiology of Drug-Induced Liver Injury in Mainland China
Shen, T., Liu, Y., Shang, J., Xie, Q., Li, J., Yan, M., Xu, J., Niu, J., Liu, J., Watkins, P. B., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.02.002 · Cited by 615
Zhou, F., Zhou, J., Wang, W., Zhang, X., Ji, Y., Zhang, P., She, Z., Zhu, L., Cai, J., & Li, H. (2019) · Hepatology · doi:10.1002/hep.30702 · Cited by 582
Self-citationEpidemiology of chronic liver diseases in the USA in the past three decades
Younossi, Z. M., Stepanova, M., Younossi, Y., Golabi, P., Mishra, A., Rafiq, N., & Henry, L. (2020) · Gut · doi:10.1136/gutjnl-2019-318813 · Cited by 549
Li, L., Liu, D. ‐., Yan, H. ‐., Wang, Z. ‐., Zhao, S. ‐., & Wang, B. (2016) · Obesity Reviews · doi:10.1111/obr.12407 · Cited by 439
Younossi, Z. M., Loomba, R., Anstee, Q. M., Rinella, M. E., Bugianesi, E., Marchesini, G., Neuschwander‐Tetri, B. A., Serfaty, L., Negro, F., Caldwell, S. H., et al. (2018) · Hepatology · doi:10.1002/hep.29721 · Cited by 431
Hsu, C., Caussy, C., Imajo, K., Chen, J., Singh, S., Kaulback, K., Le, M.-D., Hooker, J., Tu, X., Bettencourt, R., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.05.059 · Cited by 415
Pharmacotherapy for NASH: Current and emerging
Konerman, M. A., Jones, J. C., & Harrison, S. A. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.015 · Cited by 292
Mikolasevic, I., Orlic, L., Franjic, N., Hauser, G., Stimac, D., & Milic, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i32.7236 · Cited by 273
Feng, R.-N., Du, S.-S., Wang, C., Li, Y.-C., Liu, L.-Y., Guo, F.-C., & Sun, C.-H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17932 · Cited by 226
Iacono, A., Raso, G. M., Canani, R. B., Calignano, A., & Meli, R. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.10.002 · Cited by 192
Role of diet and nutritional management in non‐alcoholic fatty liver disease
Fan, J., & Cao, H. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12244 · Cited by 191
Chitturi, S., Wong, V. W., Chan, W., Wong, G. L., Wong, S. K., Sollano, J., Ni, Y., Liu, C., Lin, Y., Lesmana, L. A., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13856 · Cited by 182
Luo, Z., Li, L., & Ruan, B. (2012) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2011.10.009 · Cited by 176
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
Lazarus, J. V., Ekstedt, M., Marchesini, G., Mullen, J., Novak, K., Pericàs, J. M., Roel, E., Romero-Gómez, M., Ratziu, V., Tacke, F., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.027 · Cited by 167
Progress and challenges in the prevention and control of nonalcoholic fatty liver disease
Cai, J., Zhang, X., & Li, H. (2019) · Medicinal Research Reviews · doi:10.1002/med.21515 · Cited by 159
Self-citationHerbal medicines and nonalcoholic fatty liver disease
Yao, H., Qiao, Y.-J., Ya-li, Z., Tao, X., Xu, L., Yin, L., Qi, Y., & Peng, J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6890 · Cited by 144
Non‐alcoholic fatty liver disease: An expanding problem with low levels of awareness in Hong Kong
Leung, C. M., Lai, L. S. W., Wong, W. H., Chan, K. H., Luk, Y. W., Lai, J. Y., Yeung, Y., & Hui, W. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05914.x · Cited by 107
Bertot, L. C., Jeffrey, G. P., Wallace, M., MacQuillan, G. C., Garas, G., Ching, H. L., & Adams, L. A. (2017) · Hepatology Communications · doi:10.1002/hep4.1018 · Cited by 97
Awareness and opinions of non‐alcoholic fatty liver disease by hospital specialists
Bergqvist, C. ‐., Skoien, R., Horsfall, L. U., Clouston, A. D., Jonsson, J. R., & Powell, E. E. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2012.02848.x · Cited by 77
Study of liver cirrhosis over ten consecutive years in Southern China
Wang, X. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i37.13546 · Cited by 71
Cleveland, E. R., Ning, H., Vos, M. B., Lewis, C. E., Rinella, M. E., Carr, J. J., Lloyd‐Jones, D. M., & VanWagner, L. B. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05340-9 · Cited by 60
Singh, A., Dhaliwal, A., Singh, S., Kumar, A., López, R., Gupta, M., Noureddin, M., Carey, W., McCullough, A. J., & Alkhouri, N. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05700-9 · Cited by 58
Prevalence and Trends in Lifetime Obesity in the U.S., 1988–2014
Stokes, A., Ni, Y., & Preston, S. H. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.06.008 · Cited by 44
Ding, C., Fu, X., Zhou, Y., Liu, X., Wu, J., Huang, C., Deng, M., Li, Y., Li, L., & Yang, S. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025613 · Cited by 42
Liu, A., Galoosian, A., Kaswala, D. H., Li, A. A., Gadiparthi, C., Cholankeril, G. T., Kim, D., & Ahmed, A. (2018) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2018.00010 · Cited by 34
Piñero, F., Costa, P. E. G., BOTEON, Y. L., Duque, S. H., Marciano, S., Anders, M., Varón, A., Zerega, A. R., Poníachik, J., Soza, A., et al. (2018) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2018.03.014 · Cited by 31
Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, China
Zhang, W., Chao, S. K., Chen, S., Rao, H., Huang, R., Wei, L., & Lok, A. S.-F. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5389-5 · Cited by 30
Current and Emerging Approaches for Nonalcoholic Steatohepatitis Treatment
Chen, M., Cai, J., Yu, Y., She, Z., & Li, H. (2019) · Gene Expression · doi:10.3727/105221619x15536120524171 · Cited by 27
Self-citationXiong, J., Wang, J., Huang, J., Sun, W., Wang, J., & Chen, D. (2015) · Clinics · doi:10.6061/clinics/2015(08)06 · Cited by 23
Cited by
Global burden of liver disease: 2023 update
Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.017 · Cited by 2,267
Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
Chen, Z., Tian, R., She, Z., Cai, J., & Li, H. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.025 · Cited by 1,279
Self-citationEpidemiology of metabolic dysfunction-associated steatotic liver disease
Younossi, Z. M., Kalligeros, M., & Henry, L. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0431 · Cited by 960
Global Epidemiology and Genetics of Hepatocellular Carcinoma
Toh, M. R., Wong, E. Y. T., Wong, S. H., Ng, A. W. T., Loo, L.-H., Chow, P. K.-H., & Ngeow, J. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.01.033 · Cited by 583
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
Lei, F., Liu, Y., Zhou, F., Qin, J., Zhang, P., Zhu, L., Zhang, X., Cai, J., Lin, L., Ouyang, S., et al. (2020) · Hepatology · doi:10.1002/hep.31301 · Cited by 430
Self-citation
Metadata
- Authors
- Zhou, J., Zhou, F., Wang, W., Zhang, X., Ji, Y., Zhang, P., She, Z., Zhu, L., Cai, J., & Li, H.
- Venue
- Hepatology
- Published
- 2020-04-29
- Volume
- 71
- Issue
- 5
- Pages
- 1851-1864
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W3003865038
- Cited by
- 678
- References
- 42
- FWCI
- 54.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.